This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program
Similar Posts
Owen Biosciences, Inc. – 710275 – 10/30/2025
CGMP/Finished Pharmaceuticals/AdulteratedNeuhaus Issues Allergy Alert on Undeclared Wheat in Belgian Chocolate Moments Smurf’s Popping Milk Chocolates with Cookies’
Neuhaus Chocolates NV of Vlezenbeek, BELGIUM has initiated a voluntary recall for : Belgian Chocolate Moments Smurfs ‘Popping Milk Chocolates with Cookies, because it contains undeclared wheat. People who have an allergy or severe sensitivity to wheat run the risk of serious or life-threatening alleFDA In Brief: Findings from Real-World Data Study Reveal Higher Risk of Hospitalization and Death Among Cancer Patients with COVID-19, Underscore Health Disparities
FDA and Syapse presented Real-World Data at the American Association of Clinical Research (AACR) COVID-19 and Cancer meeting. Findings from study reveal higher risk of hospitalization and death among cancer patients with COVID-19.What’s New in Regulatory Science
A newsletter on regulatory science for CDER’s stakeholdersGlobal Generic Drug Affairs
FDA’s Office of Generic Drugs (OGD) ensures, through a scientific and regulatory process, that Americans have access to safe, effective, and high-quality generic drugs.OMUFA Reauthorization: Fiscal Years 2026 – 2030
This page is the main website for information pertaining to OMUFA reauthorization activities, including high level meeting minutes with industry while negotiations are ongoing.